Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Tesson

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Lancet. Oncology|June 13, 2018
Predictive gene-expression score for follicular lymphoma - Authors' replySarah Huet, Bruno Tesson, Gilles Salles
BMC Genomics|June 6, 2015
Detection of miRNA regulatory effect on triple negative breast cancer transcriptomeLoredana Martignetti, Bruno Tesson, Anna Almeida, et al.
Nature Immunology|August 15, 2018
Human germinal center transcriptional programs are de-synchronized in B cell lymphomaPierre Milpied, Iñaki Cervera-Marzal, Marie-Laure Mollichella, et al.
Plos One|April 8, 2015
Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cellsSylvie Maubant, Bruno Tesson, Virginie Maire, et al.
British Journal of Haematology|May 23, 2023
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimenCamille Laurent, Maria Flores, Loïc Chartier, et al.
Blood|July 7, 2017
Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytesBruno Tesson, Sarah Huet, Béatrice Grange, et al.
American Journal of Hematology|March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximabSarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.
British Journal of Haematology|June 22, 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copiesLucile Bussot, Simon Chevalier, Justine Cristante, et al.
Blood|October 7, 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significanceCamille Laurent, Preeti Trisal, Bruno Tesson, et al.
Plos One|May 24, 2013
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancerVirginie Maire, Céline Baldeyron, Marion Richardson, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Lancet. Oncology|June 13, 2018
Predictive gene-expression score for follicular lymphoma - Authors' replySarah Huet, Bruno Tesson, Gilles Salles
BMC Genomics|June 6, 2015
Detection of miRNA regulatory effect on triple negative breast cancer transcriptomeLoredana Martignetti, Bruno Tesson, Anna Almeida, et al.
Nature Immunology|August 15, 2018
Human germinal center transcriptional programs are de-synchronized in B cell lymphomaPierre Milpied, Iñaki Cervera-Marzal, Marie-Laure Mollichella, et al.
Plos One|April 8, 2015
Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cellsSylvie Maubant, Bruno Tesson, Virginie Maire, et al.
British Journal of Haematology|May 23, 2023
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimenCamille Laurent, Maria Flores, Loïc Chartier, et al.
Blood|July 7, 2017
Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytesBruno Tesson, Sarah Huet, Béatrice Grange, et al.
American Journal of Hematology|March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximabSarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.
British Journal of Haematology|June 22, 2021
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copiesLucile Bussot, Simon Chevalier, Justine Cristante, et al.
Blood|October 7, 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significanceCamille Laurent, Preeti Trisal, Bruno Tesson, et al.
Plos One|May 24, 2013
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancerVirginie Maire, Céline Baldeyron, Marion Richardson, et al.
Pageof 3